Sharp Daily
No Result
View All Result
Friday, August 29, 2025
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
Sharp Daily
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
No Result
View All Result
Sharp Daily
No Result
View All Result
Home Healthcare

PPB and ACA sign MoU to combat counterfeit medicine

Brenda Murungi by Brenda Murungi
January 17, 2024
in Healthcare, News
Reading Time: 2 mins read

The Anti-Counterfeit Authority (ACA) and the Pharmacy and Poisons Board (PPB) have entered into a Memorandum of Understanding (MoU) amid an escalating threat to public safety from the increasing influx of counterfeit pharmaceutical products.

ACA identifies emergency contraception, malaria drugs, and beauty products as the most frequently counterfeited items in the country. The Authority acknowledges that illicit trade in Kenya exceeded KES 1 trillion by 2023, with counterfeit trade contributing between KES 80 billion and KES 100 billion to this total.

The MoU aims to strengthen oversight and enforce the rights of health product and technology owners. Its primary focus is preventing the distribution of counterfeit health products within Kenya’s borders.

The agreement establishes a comprehensive framework that includes elements such as information exchange, collaborative investigations, capacity building, research, regulatory alignment, and consistent communication among the involved agencies.

RELATEDPOSTS

Deadly human-wildlife conflict in Nairobi and Nyeri

April 22, 2025

Pharmacy board clears Mefenamic Acid suspension for market distribution

March 18, 2025

Counterfeit product prevalence in Kenya is largely attributed to porous borders, with 80 percent of fake goods entering from neighboring countries. The Pharmacy and Poisons Board (PPB) notes that its ability to control the influx of counterfeit pharmaceutical products is hindered by insufficient resources.

PPB CEO Dr. Fred Siyoi highlights challenges posed by advancements in technology, such as AI and social media platforms like TikTok, where unauthorized advertisements for medicine may proliferate beyond regulatory control. He emphasizes the difficulty in managing platforms like TikTok and other emerging channels due to limited resources.

Dr. Njoroge underscores the importance of recording intellectual property rights and collaborating with various government agencies to combat the growing menace of counterfeit trade in the country.

Previous Post

NIBS founder Lizzie Wanyoike set to be buried next Tuesday

Next Post

Heri Holdings acquires Nova Academies’ property arm with regulator’s nod

Brenda Murungi

Brenda Murungi

Related Posts

News

Kick financial goals: Invest with CMMF this football season

August 22, 2025
Analysis

Kenya’s Interest Rate Cut: A Turning Point for Growth

July 31, 2025
commercial illustrator
News

Why Kenyan private equity firms should consider continuation funds as an exit strategy

July 23, 2025
Business

Del Monte foods files for bankruptcy in USA

July 3, 2025
News

Private vs Public Pension Funds in Kenya

June 30, 2025
Analysis

Kenya’s CIS market: Q1′ 2025 shows a surge, setting the stage for future expansion.

June 26, 2025

LATEST STORIES

The Importance of Including Pension Plans in Corporate Benefits Packages

August 29, 2025

The informal labor market and classical unemployment in the Kenyan context

August 28, 2025

Kenya’s Eurobond yields ease after S&P rating upgrade

August 28, 2025

Kenya’s strategic debt pivot: Smoothing, Strengthening, Sustaining

August 27, 2025

Bank on your paycheck: Invest smart with CMMF

August 26, 2025

Finding Balance: My Journey with Internet Self-Care

August 22, 2025

Why Young Kenyans Cannot Afford to Ignore Private Pensions

August 22, 2025

Strategies for Nairobi to emerge as Africa’s financial hub

August 22, 2025
  • About Us
  • Meet The Team
  • Careers
  • Privacy Policy
  • Terms and Conditions
Email us: editor@thesharpdaily.com

Sharp Daily © 2024

No Result
View All Result
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team

Sharp Daily © 2024